Use of antioxidant supplements in the treatment of human oral leukoplakia: Review of the literature and current studies

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 81, Issue 1, 1996, Pages 5-14

  Kaugars, George E ^a   Silverman Jr , Sol ^b   Lovas, John G L ^c   Thompson, Joan S ^d   Brandt, Richard B ^a   Singh, Vishwa N ^e  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DALHOUSIE UNIVERSITY   (Canada)

^d WEBER STATE UNIVERSITY   (United States)

^e HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ISOTRETINOIN; KERATOLYTIC AGENT;

ADJUVANT CHEMOTHERAPY; ANIMAL; CARCINOMA; CELL TRANSFORMATION; CLINICAL TRIAL; DRUG COMBINATION; HUMAN; LEUKOPLAKIA; MOUTH TUMOR; PATHOLOGY; RECURRENT DISEASE; REVIEW;

ANIMALS; ANTIOXIDANTS; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; DRUG COMBINATIONS; HUMANS; ISOTRETINOIN; KERATOLYTIC AGENTS; LEUKOPLAKIA, ORAL; MOUTH NEOPLASMS; RECURRENCE;

EID: 0029678088     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-2104(96)80139-9     Document Type: Review

References (126)

1. Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta-carotene materially reduce cancer rates? Nature 1981; 290:201-8.
2. Gaby SK, Bendich A. Vitamin A. In: Gaby SK, Bendich A, Singh VN, Machlin LJ, eds. Vitamin intake and health. New York: Marcel Dekker, 1991:17-27.
3. Machlin LJ, Bendich A. Free radical tissue damage: protective role of antioxidant nutrients. FASEB J 1987;1:441-5.
4. Gaby SK, Singh VN. Beta-carotene. In: Gaby SK, Bendich A, Singh VN, Machlin LJ, eds. Vitamin intake and health. New York: Marcel Dekker, 1991:29-57.
5. Slater TF. Concluding remarks. Am J Clin Nutr 1991;53:394S-6S.
6. Garewal HS, Meyskens FL, Killen D, et al. Response of oral leukoplakia to beta-carotene. J Clin Oncol 1990;8:1715-20.
7. Kaugars GE, Brandt RB, Carcaise-Edinboro P, Strauss R. Beta-carotene supplementation in the treatment of oral lesions [Abstract]. ORAL SURG ORAL MED ORAL PATHOL 1990;70:607-8.
8. Toma S, Albanese M, De Lorenzi M, et al. Beta-carotene in the treatment of oral leukoplakia [Abstract]. Proc Am Soc Clin Oncol 1990;9:179.
9. Hong WK, Endicott J, Itri LM. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986;315:1501-5.
10. Lippman SM, Toth BB, Batsakis JG, et al. Low-dose 13-cis-retinoic acid (13cRA) maintains remission in oral premalignancy: more effective than beta-carotene in ran-domized trial [Abstract]. Proc Am Soc Clin Oncol 1990;9:59.
11. Garewal HS, Meyskens F. Retinoids and carotenoids in the prevention of oral cancer: a critical appraisal. Cancer Epidemiol Biomarkers Prev 1992;1:155-9.
12. Garewal HS, Schantz SP. Emerging role of beta-carotene and antioxidant nutrients in the prevention of oral cancer. Arch Otolaryngol Head Neck Surg 1995;121:141-4.
13. Krause MV, Mahan KL. Food, nutrition, and diet therapy. Philadelphia: WB Saunders, 1984:102-7.
14. Mahan L, Arlin M. Krause's food, nutrition, and diet therapy. Philadelphia: WB Saunders, 1992.
15. Marks J. The vitamins: their role in medical practice. Lancaster, England: MTP Press, Ltd, 1985:111-93.
16. Krinsky NI. Beta-carotene:functions. In: New protective roles for selected nutrients. Alan R Liss, 1989:1-15.
17. Groff J, Gropper S, Hunt S. Advanced nutrition and human metabolism. St. Paul, Minnesota: West Publishing, 1995.
18. Wald N. Retinol, beta-carotene, and cancer. Cancer Surv 1987;6:635-51.
19. Russell-Briefel R, Bates MW, Kuller LH. The relationship of plasma carotenoids to health and biochemical factors in middle-aged men. Am J Epidemiol 1985;122:741-9.
20. Aoki K, Ito Y, Sasaki R, et al. Smoking, alcohol drinking, and serum carotenoids levels [Abstract]. Jpn J Cancer Res 1987;78:1049-56.
21. Stryker WS, Kaplan LA, Stein EA, et al. The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am J Epidemiol 1988;127:283-96.
22. Nierenberg DW, Stukel TA, Baron JA, Dain BJ, Greenberg ER. Determinants of increase in plasma concentration of beta-carotene after chronic oral supplementation. Am J Clin Nutr 1991;53:443-9.
23. Constantino JP, Kuller LH, Begg L. Serum level changes after administration of a pharmacologic dose of beta-carotene. Am J Clin Nutr 1988;48:1277-83.
24. Silverman S Jr, Kaugars GE, Gallo J, Thompson J, Stites DP, Brandt RB. Clinical and lymphocyte responses to beta-carotene supplementation in 11 HIV-positive patients with chronic oral candidiasis. ORAL SURG ORAL MED ORAL PATHOL 1994;78:442-7.
25. Carlier C, Etchepare M, Periquet B, Amedee-Manesme O. A randomized controlled trial to test equivalence between retinyl palmitate and beta-carotene for vitamin A deficiency. BMJ 1994;307:1106-10.
26. Henderson CT, Mobarhan S, Bowen P, et al. Normal serum response to oral beta-carotene in humans. J Am Coll Nutr 1989;8:625-35.
27. Mathews-Roth MM. Beta-carotene: clinical aspects. In: New protective roles for selected nutrients. Alan R Liss, 1989:17-38.
28. Suda D, Schwartz J, Shklar G. Inhibition of experimental oral carcinogenesis by topical beta-carotene. Carcinogenesis 1986;7:711-5.
29. Bendich A, Olson JA. Biological actions of carotenoids. FASEB J 1989;3:1927-32.
30. Schwartz J, Suda D, Light G. Beta-carotene is associated with the regression of hamster buccal pouch carcinoma and the induction of tumor necrosis factor in macrophages. Biochem Biophys Res Commun 1986;136:1130-5.
31. Prabhala RH, Garewal HS, Hicks MJ, Sampliner RE, Watson RR. The effects of 13-cis-retinoic acid and beta-carotene on cellular immunity in humans. Cancer 1991;67:1556-60.
32. Bendich A. Carotenoids and the immune response. J Nutr 1989;119:112-5.
33. Alexander M, Newmark H, Miller RG. Oral beta-carotene can increase the number of OKT4+ cells in human blood. Immunol Lett 1985;9:221-4.
34. Bendich A, Shapiro SS. Effect of beta-carotene and canthaxanthin on the immune responses of the rat. J Nutr 1986;116:2254-62.
35. Suda D, Schwartz J, Shklar G. Beta-carotene effects on experimental oral carcinogenesis in the hamster [Abstract]. J Dent Res 1986;65:277.
36. Rettura G, Duttagupta C, Listowsky P. Dimethylbenz(a)anthracene (DMBA) induced tumors: prevention by supplemental beta-carotene (BC) [Abstract]. Fed Proc 1983;42:786.
37. Santamaria L, Bianchi A, Arnaboldi A, et al. Chemoprevention of indirect and direct chemical carcinogenesis by carotenoids as oxygen radical quenchers. Ann N Y Acad Sci 1988;534:584-97.
38. Das BK, Sastry K. Chemopreventive effects of beta-carotene in DMBA-induced chemical carcinogenesis in rat SMG [Abstract]. J Dent Res 1995;74:465.
39. Mackerras D. Carotene intake and the risk of laryngeal cancer in coastal Texas. Am J Epidemiol 1988;128:980-7.
40. Temple NJ, Basu TK. Does beta-carotene prevent cancer? a critical appraisal. Nutr Res 1988;8:685-701.
41. Frei B. Natural antioxidants in human health and disease. San Diego: Academic Press, 1994.
42. Winn D. Diet and nutrition in the etiology of oral cancer. Am J Clin Nutr 1995;61:437S-45S.
43. Kromhout D. Essential micronutrients in relation to carcinogenesis. Am J Clin Nutr 1987;45:1361-7.
44. McLaughlin JK, Gridley G, Block G. Dietary factors in oral and pharyngeal cancer. J Natl Cancer Inst 1988;80:1237-43.
45. Singh VN, Gaby SK. Premalignant lesions: role of antioxidant vitamins and beta-carotene in risk reduction and prevention of malignant transformation. Am J Clin Nutr 1991;53:386S-90S.
46. Voelker R. Ames agrees with mom's advice: eat your fruits and vegetables. JAMA 1995;273:1077-8.
47. Franceschi S, Barra S, La Vecchia C, Bidoli E, Negri E, Talamini R. Risk factors for cancer of the tongue and the mouth: a case-control study from Northern Italy. Cancer 1992; 70:2227-33.
48. Franceschi S, Bidoli E, Baron AE, et al. Nutrition and cancer of the oral cavity and pharynx in North-east Italy. Int J Cancer 1991;47:20-5.
49. Garewal HS. Chemoprevention of oral cancer: beta-carotene and vitamin E in leukoplakia. Eur J Cancer Prev 1994;3:101-7.
50. Block G. Dietary guidelines and the results of food consumption surveys. Am J Clin Nutr 1991;53:356S-7S.
51. Serdula M, Coates R, Byers T, Simoes E, Mokdad A, Subar A. Fruit and vegetable intake among adults in 16 states: results of a brief telephone survey. Am J Public Health 1995;85:236-9.
52. Wald NJ, Thompson SG, Densem JW, Boreham J, Bailey A. Serum beta-carotene and subsequent risk of cancer: results from the BUPA study. Br J Cancer 1988;57:428-33.
53. Stahelin HB. Beta-carotene and cancer. Br J Clin Practice 1990;44:543-5.
54. Palan PR, Romney SL, Mikhail M. Decreased plasma beta-carotene levels in women with uterine cervical dysplasias and cancer. J Natl Cancer Inst 1988;80:454-5.
55. Connett JE, Kuller LH, Kjelsberg MO, et al. Relationship between carotenoids and cancer: the multiple risk factor intervention trial (MRFIT). Cancer 1989;64:126-34.
56. Heinomen OP, Albanes D. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
57. Hunter DJ, Manson JE, Colditz GA, et al. A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. N Engl J Med 1993;329:234-40.
58. Palan PR, Mikhail M, Romney SL. Decreased beta-carotene tissue levels in uterine leiomyomas and cancers of reproductive and nonreproductive organs. Am J Obstet Gynecol 1989;161:1649-52.
59. Malone WF. Studies evaluating antioxidants and beta-carotene as chemopreventives. Am J Clin Nutr 1991;53:305S-13S.
60. Pryor WA. The antioxidant nutrients and disease prevention: What do we know and what do we need to find out? Am J Clin Nutr 1991;53:391S-3S.
61. Nierenberg DW, Stukel TA, Baron JA, et al. Determinants of plasma levels of beta-carotene and retinol. Am J Epidemiol 1989;130:511-21.
62. Malaker K, Anderson BJ, Beecroft WA, Hodson DI. Management of oral mucosal dysplasia with beta-carotene and retinoic acid: a pilot cross-over study. Cancer Detect Prev 1991;15:335-40.
63. Mathews-Roth MM. Beta-carotene as an oral photoprotective agent in erythropoietic protoporphyria. JAMA 1974;228:1004-8.
64. Stich HF, Rosin MP, Hornby AP. Remission of oral leukoplakias and micronuclei in tobacco/betel nut quid chewers treated with beta-carotene and with beta-carotene plus vitamin A. Int J Cancer 1988;42:195-9.
65. Toma S, Benso S, Albanese E, et al. Treatment of oral leukoplakia with beta-carotene. Oncology 1992;49:77-81.
66. Stich HF, Hornby AP, Dunn BP. A pilot beta-carotene intervention trial with Inuits using smokeless tobacco. Int J Cancer 1985;36:321-7.
67. Stich HF, Mathew B, Sankaranarayanan R, Nair MK. Remission of oral precancerous lesions of tobacco/areca nut chewers following administration of beta-carotene or vitamin A, and maintenance of the protective effect. Cancer Detect Prev 1991;15:93-8.
68. Wills ED. Biochemical basis of medicine. Bristol, England: John Wright & Sons, Ltd, 1985:159-65.
69. Havel RJ, Galloway DH, Gussow JD, Mertz W, Nesheim MC. Fat-soluble vitamins. In: Recommended dietary allowances. Washington, DC: National Academy Press, 1989:78-93.
70. Lippman SM, Kessler JF, Meyskens FL. Retinoids as preventive and therapeutic anticancer agents (Part II). Cancer Treat Rep 1987;71:493-515.
71. Silverman S Jr, Renstrup G, Pindborg JJ. Studies in oral leukoplakias: III. effects of vitamin A comparing clinical, histopathologic, cytologic, and hematologic responses. Acta Odont Scand 1963;21:271-92.
72. Silverman S Jr, Eisenberg E, Renstrup G. A study of the effects of high doses of vitamin A on oral leukoplakia (hyper-keratosis), including toxicity, liver function, and skeletal metabolism. J Oral Ther Pharmacol 1965;2:9-23.
73. Cunliffe WJ, Miller AJ. Retinoid therapy: a review of clinical and laboratory research. Lancaster, England: MTP Press, Ltd, 1984:1-21.
74. Halter SA. Vitamin A: its role in the chemoprevention and chemotherapy of cancer. Hum Pathol 1989;20:205-9.
75. Shklar G, Schwartz J, Grau D, Trickler DP, Wallace KD. Inhibition of hamster buccal pouch carcinogenesis by 13-cis-retinoic acid. ORAL SURG ORAL MED ORAL PATHOL 1980;50:45-52.
76. Gilmore W, Giunta JL. The effect of 13-cis-retinoic acid on hamster buccal pouch carcinogenesis. ORAL SURG ORAL MED ORAL PATHOL 1981;51:256-65.
77. Inoue I, Yamamoto Y, Ito T, Takahashi H. Chemoprevention of tongue carcinogenesis in rats. ORAL SURG ORAL MED ORAL PATHOL 1993;76:608-15.
78. Lippman SM, Kessler JF, Meyskens FL. Retinoids as preventive and therapeutic anticancer agents (Pan 1). Cancer Treat Rep 1987;71:391-405.
79. DeVita VT Jr, Hellman S, Rosenberg SA. Cancer: principles and practice of oncology. Philadelphia: JB Lippincott, 1989:167-80.
80. Burton GW, Ingold KU. Beta-carotene: an unusual type of lipid antioxidant. Science 1984;224:569-73.
81. Lippman SM, Garewal HS, Meyskens FL. Retinoids as potential chemopreventive agents in squamous cell carcinoma of the head and neck. Prev Med 1989;18:740-8.
82. Koch HF. Biochemical treatment of precancerous oral lesions: the effectiveness of various analogues of retinoic acid. J Oral Maxillofac Surg 1978;6:59-63.
83. Shah IP, Strong EW, DeCosse JJ, Iri L, Sellers P. Effects of retinoids on oral leukoplakia. Am J Surg 1983;146:466-70.
84. Hays G, Lippman SM, Weber R, Batsakis J, Wargovich M, Hong W. Evaluation of a synthetic analog of vitamin A and beta carotene on the clinical and histologic appearance and biologic markers in human, premalignant oral lesions [Abstract]. ORAL SURG ORAL MED ORAL PATHOL 1991;72:311.
85. Lippman SM, Batsakis JG, Toth BB, et al. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med 1993;328:15-20.
86. Kaugars GE, Silverman S Jr. The use of 13-cis-retinoic acid in the treatment of oral leukoplakia: short-term observations. ORAL SURG ORAL MED ORAL PATHOL 1995;79:264-5.
87. Mitchell AA, Van Bennekom CM, Louik C. A pregnancy-prevention program in women of childbearing age receiving isotretinoin. N Engl J Med 1995;333:101-6.
88. Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990;323:795-801.
89. Lippman SM, Spitz M, Trizna Z, Benner SE, Hong WK. Epidemiology, biology, and chemoprevention of aerodigestive cancer. Cancer 1994;74:2719-25.
90. Sloberg K, Hersle K, Mobacken H, Thilander H. Severe oral lichen planus: remission and maintenance with vitamin A analogues. J Oral Pathol 1983;12:473-7.
91. Mahrle G, Meyer-Hamme S, Ippen H. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Arch Dermatol 1982;118:97-100.
92. Gorsky M, Raviv M. Efficacy of etretinate (Tigason) in symptomatic oral lichen planus. ORAL SURG ORAL MED ORAL PATHOL 1992;73:52-5.
93. Hersle K, Mobacken H, Sloberg K, Thilander H. Severe oral lichen planus: treatment with an aromatic retinoid (etretinate). Br J Dermatol 1982;106:77-80.
94. Lotan R, Xu X, Lippman SM, et al. Suppression of retinoic acid receptor-β in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 1995;332:1405-10.
95. Gaby SK, Singh VN. Vitamin C. In: Gaby SK, Bendich A, Singh VN, Machlin LJ, eds. Vitamin intake and health. New York: Marcel Dekker, 1991:103-61.
96. Pennington J. Bowes and Church's food values of portions commonly used. Philadelphia: JB Lippincott, 1994.
97. Havel RJ, Galloway DH, Gussow JD, Mertz W, Nesheim MC. Water-soluble vitamins. In: Recommended dietary allowances. Washington, D.C.: National Academy Press, 1989:115-24.
98. Alpers DH, Clouse RE, Stenson WF. Manual of nutritional therapeutics. Boston: Little, Brown, and Company, 1983:28-47.
99. Block G. Vitamin C and cancer prevention: the epidemiologic evidence. Am J Clin Nutr 1991;53:270S-82S.
100. Shklar G, Schwartz J, Trickler D. Vitamin C augments DMBA carcinogenesis of hamster buccal pouch [Abstract]. J Dent Res 1991;70:594.
101. Schwartz J, Shklar G, Trickier D. Vitamin C enhances the development of carcinomas in the hamster buccal pouch experimental model. ORAL SURG ORAL MED ORAL PATHOL 1993;76:718-22.
102. Mirvish SS. Effects of vitamins C and E on N-nitroso compound formation, carcinogenesis, and cancer. Cancer 1986;58:1842-50.
103. Diplock AT. Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr 1991;53:189S-93S.
104. Stahelin HB, Gey KF, Eichholzer M, et al. Plasma antioxidant vitamins and subsequent cancer mortality in the 12-year follow-up of the prospective Basel study. Am J Epidemiol 1991;133:766-75.
105. Havel RJ, Galloway DH, Gussow JD, Mertz W, Nesheim MC. Fat-soluble vitamins. In: Recommended dietary allowances. Washington, D.C.: National Academy Press, 1989:99-107.
106. Bendich A, Machlin LJ. Safety of oral intake of vitamin E. Am J Clin Nutr 1988;48:612-9.
107. Tengerdy RP. Vitamin E, immune response, and disease resistance. N Y Acad Sci 1989;570:335-44.
108. Pollack RL, Morse DR. Free radicals and antioxidants: relation to chronic diseases and aging. Int J Psychosom 1988;35:43-8.
109. Gridley G, McLaughlin JK, Block G, Blot WJ, Gluch M, Fraumeni JF Jr. Vitamin supplement use and reduced risk of oral and pharyngeal cancer. Am J Epidemiol 1992;135:1083-92.
110. Bendich A, Gabriel E, Machlin LJ. Effect of dietary level of vitamin E on the immune system of the spontaneously hypertensive (SHR) and normotensive Wistar Kyoto (WKY) rat. J Nutr 1983;113:1920-6.
111. Watson RR, Leonard TK. Selenium and vitamins A, E, and C: nutrients with cancer prevention properties. J Am Diet Assoc 1986;86:505-10.
112. Meydani SN, Meydani M, Barkland PM. Effect of vitamin E supplementation on immune responsiveness of the aged. N Y Acad Sci 1989;570:283-90.
113. Gaby SK, Machlin LJ. Vitamin E. In: Gaby SK, Bendich A, Singh VN, Machlin LJ, eds. Vitamin intake and health. New York: Marcel Dekker, 1991:71-101.
114. Elattar T, Lin H. Effect of vitamins A, C, and E on prostaglandin production by oral squamous carcinoma cells [Abstract]. J Dent Res 1992;72:707.
115. Shklar G, Schwartz JL, Trickier D, Reid S. Prevention of experimental cancer and immunostimulation by vitamin E (immunosurveillance). J Oral Pathol Med 1990;19:60-4.
116. Shklar DP, Schwartz JL. Vitamin E inhibits oral carcinogenesis and tumor angiogenesis [Abstract]. J Dent Res 1995;74:88.
117. Knekt P, Aromaa A, Maatela J, et al. Vitamin E and cancer prevention. Am J Clin Nutr 1991;53:283S-6S.
118. Benner SE, Winn RJ, Lippman SM, et al. Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study. J Natl Cancer Inst 1993;85:44-7.
119. Ginter E, Kosinova A, Hudecova A, Madaric A. Synergism between vitamins C and E: effect on microsomal hydroxylation in guinea pig liver. Int J Vitam Nutr Res 1982;52:55-9.
120. Niki E, Kawakami A, Yamamoto Y, Kamiya Y. Oxidation of lipids: VIII. synergistic inhibition of oxidation of phosphatidycholine liposome in aqueous dispersion by vitamin E and vitamin C. Bull Chem Soc Jpn 1985;58:1971-5.
121. Shklar G, Schwartz J, Trickier D, Reid S. Regression of experimental cancer by oral administration of combined alpha-tocopherol and beta-carotene. Nutr Cancer 1989;12:321-5.
122. Schwartz JL, Tanaka V, Khandekar V, Herman TS, Teicher BA. Beta-carotene and/or vitamin E as modulators of alkylating agents in SCC-25 human squamous carcinoma cells. Cancer Chemother Pharmacol 1992;29:207-13.
123. Comstock GW, Bush TL, Helzlsouer K. Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites. Am J Epidemiol 1992;135:115-21.
124. Xu M, Plezia P, Alberts D, et al. Reduction in plasma or skin alpha-tocopherol concentration with long-term administration of beta-carotene in humans and mice. J Natl Cancer Inst 1992;84:1559-65.
125. Nierenberg DW, Stukel TA, Mott L, Greenberg ER. Steady-state serum concentration of alpha-tocopherol not altered by supplementation with oral beta-carotene. J Natl Cancer Inst 1994;86:117-20.
126. Kaugars GE, Silverman S Jr, Lovas JGL, et al. A clinical trial of antioxidant supplements in the treatment of oral leukoplakia. ORAL SURG ORAL MED ORAL PATHOL 1994;78:462-8.